The WHO classification primarily relies on the histological analysis of the tumor tissue. This involves examining the microscopic features of the tumor cells, such as cell type, cell morphology, and the pattern of cell growth. In recent years, the classification has been updated to include molecular markers and genetic alterations, which can provide additional prognostic information and guide targeted therapies.
